Latest News and Press Releases

Paris, France, Cambridge, USA, July 23, 2025 - TISSIUM, a MedTech company pioneering biomorphic programmable polymers for tissue reconstruction, today announced the commercial launch of...

Ce jalon réglementaire marque l’entrée de TISSIUM sur le marché américain et établit les fondations de sa plateforme de polymères dédiés à la reconstruction atraumatique des tissus. Paris...

This regulatory milestone marks TISSIUM’s entry into the U.S. market and establishes the foundation of the TISSIUM polymer platform for atraumatic tissue repair Paris, France, Cambridge, USA,...

Paris, France, le 5 juin 2025 -- TISSIUM, société de medtech spécialisée dans le développement de polymères programmables biomorphiques pour la reconstruction des tissus, confirme sa place, pour la...

Paris, France, June 5, 2025 -- TISSIUM, a medtech company developing biomorphic programmable polymers for tissue reconstruction, confirms its selection for the sixth year in a row in the French Tech...

Paris, France, Cambridge, USA, April 2nd, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, is proud to unveil clinical data...

Paris, France, Cambridge, USA, February 25, 2025 - TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today the expansion of...